# Oral AQX-1125 and Combination Oral Contraceptive Drug-Drug Interaction Study

> **NCT03478020** · PHASE1 · COMPLETED · sponsor: **Aquinox Pharmaceuticals (Canada) Inc.** · enrollment: 32 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** AQX-1125
- **DRUG:** Combined Oral Contraceptive

## Key facts

- **NCT ID:** NCT03478020
- **Lead sponsor:** Aquinox Pharmaceuticals (Canada) Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-22
- **Primary completion:** 2018-03-29
- **Final completion:** 2018-04-05
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2018-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03478020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03478020, "Oral AQX-1125 and Combination Oral Contraceptive Drug-Drug Interaction Study". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT03478020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*